Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Autoimmunity is a well-known pathogenic component in type 1 diabetes (T1DM). The assumption that the pathogenesis of type 2 diabetes (T2DM) also encompasses autoimmune aspects is recognized increasingly, based on the presence of circulating autoantibodies against β cells, self-reactive T cells, but also on the glucose-lowering efficacy of some immunomodulatory therapies in T2DM. The identification of these autoantibodies in elderly patients with slowly progressive manifestation of diabetes led to the introduction of a distinct clinical entity termed latent autoimmune diabetes of the adult (LADA), which combines features of both T1DM and T2DM. The autoantibody cluster differs in patients with LADA from patients with T1DM, but their presence indicates steady progression towards β-cell death and subsequent need for initiation of insulin treatment in a shorter period of time compared to autoantibody-negative T2DM patients. Autoimmune aspects in T2DM are not solely restricted to autoantibodies and thus LADA. They include the self-reactive T cells or defects in regulatory T cells (Tregs), which have been detected in autoantibody-negative T2DM patients as well. One contributor to the autoimmune activation in T2DM seems to be the chronic inflammatory state, characteristic of this disease. Upon inflammation-induced tissue destruction, cryptic ‘self' antigens can trigger an autoimmune response, which in turn accelerates β-cell death. Both innate and adaptive immune system components, specifically macrophages and self-reactive T cells, contribute to an increased secretion of inflammatory cytokines involved in inflammatory and autoimmune processes. However, the extent to which inflammation overlaps with autoimmunity is not known. Our review focuses on autoimmune involvement in T2DM, with an emphasis on LADA and the humoral immune response, on the involvement of chronic inflammation in autoimmunity, and specifically the role of B and T cells as links between inflammatory and autoimmune reactions. We will further stress the consequences of autoimmune activation for T2DM patients and present novel therapeutic approaches for T2DM management that rely on immune modulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, over recent years, it has become increasingly recognised that the aetiology of T2D encompasses autoimmune activity, similar to T1D.313”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [313]
In the citing paper
“Strikingly, studies have demonstrated that islet-reactive T-cells can be found in phenotypic human T2D patients, and many studies have found that a subset of T2D patients test positive for islet beta-cell autoantibodies - these T-cells and antibodies are usually associated with T1D pathogenesis.313”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [313]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Danger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J., et al. (2012) · Science · doi:10.1126/science.1215327 · Cited by 739
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623
Lupi, R., Dotta, F., Marselli, L., Del Guerra, S., Masini, M., Santangelo, C., Patané, G., Boggi, U., Piro, S., Anello, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1437 · Cited by 595
Tuomi, T., Groop, L. C., Zimmet, P. Z., Rowley, M. J., Knowles, W., & Mackay, I. R. (1993) · Diabetes · doi:10.2337/diab.42.2.359 · Cited by 581
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Shevach, E. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.003 · Cited by 549
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi, T., Carlsson, A., Li, H., Isomaa, B., Miettinen, A., Nilsson, A., Nissén, M., Ehrnström, B. O., Forsén, B., Snickars, B., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.1.150 · Cited by 502
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Adiponectin and inflammation: Consensus and controversy
Fantuzzi, G. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.018 · Cited by 404
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care · doi:10.2337/dc09-0533 · Cited by 401
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Pyle, L., Staten, M. A., Shoelson, S. E., & for the TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-6-201003160-00004 · Cited by 388
Obesity predisposes to Th17 bias
Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., & Dosch, H. ‐. (2009) · European Journal of Immunology · doi:10.1002/eji.200838893 · Cited by 377
Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
Obesity, Inflammation, and Insulin Resistance – A Mini-Review
Zeyda, M., & Stulnig, T. M. (2009) · Gerontology · doi:10.1159/000212758 · Cited by 366
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0931 · Cited by 339
Eller, K., Kirsch, A., Wolf, A. M., Sopper, S., Tagwerker, A., Stanzl, U., Wolf, D., Patsch, W., Rosenkranz, A. R., & Eller, P. (2011) · Diabetes · doi:10.2337/db11-0358 · Cited by 318
Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity
Duffaut, C., Galitzky, J., Lafontan, M., & Bouloumié, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.002 · Cited by 299
Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287
Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult)
Pozzilli, P., & Di Mario, U. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1460 · Cited by 284
Latent Autoimmune Diabetes in Adults
Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1120 · Cited by 249
Shaking the tree: mapping complex disease genes with linkage disequilibrium
Palmer, L. J., & Cardon, L. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67485-5 · Cited by 234
Cervin, C., Lyssenko, V., Bakhtadze, E., Lindholm, E., Nilsson, P., Tuomi, T., Cilio, C. M., & Groop, L. (2008) · Diabetes · doi:10.2337/db07-0299 · Cited by 230
Itariu, B. K., Zeyda, M., Hochbrugger, E. E., Neuhofer, A., Prager, G., Schindler, K., Bohdjalian, A., Mascher, D., Vangala, S., Schranz, M., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037432 · Cited by 227
Self-citationIrvine, W. J., Gray, R. S., Mccallum, C. J., & Duncan, L. J. P. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91258-2 · Cited by 172
Borg, H., Gottsäter, A., Fernlund, P., & Sundkvist, G. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1754 · Cited by 168
Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
Pietropaolo, M., Barinas-Mitchell, E., Pietropaolo, S. L., Kuller, L. H., & Trucco, M. (2000) · Diabetes · doi:10.2337/diabetes.49.1.32 · Cited by 159
Toll-like receptors regulate B cell cytokine production in patients with diabetes
Jagannathan, M., McDonnell, M., Liang, Y., Hasturk, H., Hetzel, J., Rubin, D., Kantarci, A., Van Dyke, T. E., Ganley-Leal, L. M., & Nikolajczyk, B. S. (2010) · Diabetologia · doi:10.1007/s00125-010-1730-z · Cited by 156
Poggi, M., Jager, J., Paulmyer‐Lacroix, O., Peiretti, F., Grémeaux, T., Verdier, M., Grino, M., Stépanian, A., Msika, S., Burcelin, R., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1267-1 · Cited by 146
Zeyda, M., Huber, J., Prager, G., & Stulnig, T. M. (2011) · Obesity · doi:10.1038/oby.2010.123 · Cited by 143
Self-citationA Clinical Screening Tool Identifies Autoimmune Diabetes in Adults
Fourlanos, S., Perry, C., Stein, M. S., Stankovich, J., Harrison, L. C., & Colman, P. G. (2006) · Diabetes Care · doi:10.2337/dc05-2101 · Cited by 127
DPP-4 inhibitors in the treatment of type 2 diabetes
Duez, H., Cariou, B., & Staels, B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.028 · Cited by 110
Clustering and commonalities among autoimmune diseases
Mackay, I. R. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.006 · Cited by 110
Gambelunghe, G., Forini, F., Laureti, S., Murdolo, G., Toraldo, G., Santeusanio, F., Brunetti, P., Sanjeevi, C. B., & Falorni, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00983.x · Cited by 108
Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes
Twomey, P. J., Viljoen, A., Reynolds, T. M., & Wierzbicki, A. S. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2569 · Cited by 106
Kim, S.-J., Nian, C., Doudet, D. J., & McIntosh, C. H. S. (2009) · Diabetes · doi:10.2337/db08-1101 · Cited by 106
Cole, B. K., Keller, S. R., Wu, R., Carter, J. D., Nadler, J. L., & Nunemaker, C. S. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148049 · Cited by 93
Zeyda, M., Szekeres, A. B., Säemann, M. D., Geyeregger, R., Stockinger, H., Zlabinger, G. J., Waldhäusl, W., & Stulnig, T. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6033 · Cited by 89
Self-citationInflammasome activation in obesity-related inflammatory diseases and autoimmunity.
Lukens, J. R., Dixit, V. D., & Kanneganti, T. (2011) · PubMed · Cited by 89
Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P. (2011) · Diabetes Care · doi:10.2337/dc10-0579 · Cited by 83
Brooks-Worrell, B., & Palmer, J. P. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04501.x · Cited by 82
Falorni, A., Gambelunghe, G., Forini, F., Kassi, G., Cosentino, A., Candeloro, P., Bolli, G. B., Brunetti, P., & Calcinaro, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6301 · Cited by 77
Clinical phenotype and β-cell autoimmunity in Italian patients with adult-onset diabetes
Genovese, S., Bazzigaluppi, E., Gonçalves, D., Ciucci, A., Cavallo, M. G., Purrello, F., Anello, M., Rotella, C. M., Bardini, G., Vaccaro, O., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02115 · Cited by 58
Falorni, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.309 · Cited by 58
Reappraising the stereotypes of diabetes in the modern diabetogenic environment
Wentworth, J. M., Fourlanos, S., & Harrison, L. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.149 · Cited by 57
Haskell, B. D., Flurkey, K., Duffy, T. M., Sargent, E. E., & Leiter, E. H. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000018915.53257.00 · Cited by 47
Prevalence of GAD65 Antibodies in Lean Subjects with Type 2 Diabetes
Unnikrishnan, A. G., Singh, S., & Sanjeevi, C. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1337.018 · Cited by 36
Induction of Immunological Tolerance by Oral Anti-CD3
da Cunha, A. P., & Weiner, H. L. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/425021 · Cited by 34
Römkens, T., Kusters, G. C. M., Netea, M. G., & Netten, P. M. (2006) · PubMed · Cited by 31
Bruno, G., Salvia, A. D., Arcari, R., Borra, M., Grosso, N., Carta, Q., Trovati, M., Veglio, M., & Pagano, G. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.50 · Cited by 30
A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults
Fourlanos, S. (2006) · Diabetes Care · doi:10.2337/diacare.295970 · Cited by 30
Ursini, F., Mauro, D., Naty, S., Gagliardi, D., & Grembiale, R. D. (2012) · Clinical Rheumatology · doi:10.1007/s10067-012-2034-0 · Cited by 25
Functional State of the β Cell Affects Expression of Both Forms of Glutamic Acid Decarboxylase
Hao, W., Li, T., Mehta, V. K., Lernmark, Å., & Palmer, J. P. (1994) · Pancreas · doi:10.1097/00006676-199409000-00003 · Cited by 24
Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay
McCulloch, D. K., Bärmeier, H., Neifing, J. L., & Palmer, J. P. (1991) · Diabetologia · doi:10.1007/bf00400990 · Cited by 23
Race and diabetic nephropathy.
Friedman, E. A. (1987) · PubMed · Cited by 14
Kelly, M. A., Chan, J. C. N., Heward, J., Mijovic, C. H., Zimmet, P., Yeung, V. T. F., Cockram, C. S., & Barnett, A. H. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00400.x · Cited by 11
Research works printed but not linked: 2
- 10.1210/jc.87.3.1184 · doi:10.1210/jc.87.3.1184 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Adult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
“Furthermore, a new autoantibody against the extracytoplasmatic (EC) IA-2EC(26-577) region can identify a novel antigenic determinant within the N terminus of the IA-2 protein76.”
BackgroundProfile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
Grossmann, V., Schmitt, V. H., Zeller, T., Panova-Noeva, M., Schulz, A., Laubert-Reh, D., Juenger, C., Schnabel, R. B., Abt, T. G. J., Laskowski, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3008 · Cited by 257
“to an islet cell autoimmunity in type 2 diabetes through activation of T cells, B cells, and macrophages, increased expression of b-cell antigens, and subsequent b-cell apoptosis (5).”
BackgroundInfluentialAn Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
Ota, A., & Ulrih, N. P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00436 · Cited by 216
“Recent studies have also shown the pathological involvement of the immune system in type 2 diabetes, that is, based on the presence of autoantibodies against β cells, selfreactive T cells and evidence of beneficial effect of some antiinflammatory and immunomodulatory therapy, being viewed as an autoinflammatory diseas…”
Backgroundde Melo, L. G. P., Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Galecki, P., Carvalho, A. F., & Maes, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 189
Metadata
- Authors
- Itariu, B. K., & Stulnig, T. M.
- Affiliations
- Medical University of Vienna (AT)
- Venue
- Gerontology
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 60
- Issue
- 3
- Pages
- 189-196
- ISSN
- 0304-324X (ISSN-L)
- 1423-0003
- OpenAlex
- W2043428857
- Cited by
- 107
- References
- 69
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 12 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 5
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, autoimmunity, beta-cell autoantibodies, autoreactive T cells, regulatory T cells, chronic inflammation, beta-cell death, immunomodulatory therapy, B cells, T cells, macrophages, inflammatory cytokines, elderly patients
- MeSH terms
- Adult, Aged, Animals, Autoimmune Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glutamate Decarboxylase, Humans, Lymphocytes, Male, Middle Aged, Autoimmunity, Models, Immunological, Insulin-Secreting Cells, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.